In the SEM analysis, we posited that cardiometabolic measures (hypertension, type 2 diabetes, hypercholesterolemia), BMI and Aβ status are influenced by age, sex, APOE ε4 status, and region of residence, which may, in turn, influence CMHs prevalence. The gene discussed is APOE; the disease is type 2 diabetes mellitus.